First Trust Health Care AlphaDEX Fund (FXH): outlook, holdings and fees
First Trust Health Care AlphaDEX Fund (FXH) is an exchange-traded fund and is managed by First Trust. The expense ratio is 0.58% and the yield is 0.55%. The ten largest holdings are 24% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on FXH
| Last price | $137.81 (+0.3%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 55% |
| Likely 1-month range (50%) | $134.64 – $142.39 |
| Normal 1-day range (±1σ) | ±1.0% |
| Distribution yield | 0.55% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
FXH fund facts
| Issuer | First Trust |
|---|---|
| Theme | Healthcare |
| Assets under management | $1.1B |
| Expense ratio | 0.58% |
| Number of holdings | 50 |
| Portfolio turnover | 0% |
| Inception | May 8, 2007 |
| Exchange | NYSE |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.
FXH top holdings
| Holding | Sector | Weight |
|---|---|---|
| Centene Corp CNC | Healthcare | 2.40% |
| Corcept Therapeutics Incorporated CORT | Healthcare | 2.53% |
| Cigna Corp CI | Healthcare | 2.60% |
| Universal Health Services Inc UHS | Healthcare | 2.51% |
| Zimmer Biomet Holdings Inc ZBH | Healthcare | 2.49% |
| Halozyme Therapeutics Inc HALO | Healthcare | 2.30% |
| Globus Medical GMED | Healthcare | 2.45% |
| Solventum Corp. SOLV | Healthcare | 2.48% |
| Medpace Holdings Inc MEDP | Healthcare | 2.28% |
| DexCom Inc DXCM | Healthcare | 2.41% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
FXH sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 100.0%.
FXH returns and risk
| Year to date | +15.2% |
|---|---|
| 1 year | +20.7% |
| 3 years (annualised) | +11.6% |
| 5 years (annualised) | +2.8% |
| 10 years (annualised) | +8.3% |
| Volatility (3 years) | 14.8% |
| Sharpe ratio (3 years) | 0.48 |
Past returns do not guarantee future results.
FXH: frequently asked questions
What does FXH invest in?
First Trust Health Care AlphaDEX Fund invests in a portfolio of securities. Its largest holdings are Centene Corp (2.4%), Corcept Therapeutics Incorporated (2.5%), Cigna Corp (2.6%), Universal Health Services Inc (2.5%), Zimmer Biomet Holdings Inc (2.5%).
What is the FXH expense ratio?
0.58% a year: about $58.00 for every $10,000 invested.
What is the FXH dividend yield?
0.55%. ATLAS does not hold the exact distribution dates for ETFs.
Will FXH go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 55%, with a likely range (50%) of $134.64 to $142.39 from $137.81 today. It is a probability, not a prediction.
How has FXH performed?
Year to date +15.2%, one year +20.7%, three years +11.6% a year, five years +2.8% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- State Street Health Care Select Sector SPDR ETF (XLV)
- Vanguard Health Care ETF (VHT)
- iShares Global Healthcare ETF (IXJ)
- iShares U.S. Healthcare ETF (IYH)
- iShares U.S. Medical Devices ETF (IHI)
- Fidelity MSCI Health Care Index ETF (FHLC)
- iShares U.S. Pharmaceuticals ETF (IHE)
- First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Educational information, not investment advice. Disclaimer